Skip to Main Content

Author Details

Mieke Van Hemelrijck
School of Cancer and Pharmaceutical Sciences, King's College London
2007
342
44
PMIDPaper TitleJournal TitlePublished Year
37414703Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.Eur Urol2024
38083979Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis.Int J Cancer2024
37988643Reply to R. Sun et al.J Clin Oncol2024
38029831Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.Int J Infect Dis2024
35088246Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.J Cancer Surviv2023
37636213A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS).BJUI Compass2023
37561978Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus Process.JCO Glob Oncol2023
37526700The impact of 2 weeks wait referral on survival of head and neck cancer patients.Eur Arch Otorhinolaryngol2023
37802612<b>CO</b>mparing Urolift and <b>S</b>tandard <b>T</b>ransurethral resection of prostate <b>A</b>head of <b>R</b>adiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study.BMJ Open2023
37701044Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?Pragmat Obs Res2023
37611139Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the program.Br J Surg2023
38046899Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program.Int J Surg Protoc2023
37499209Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.J Clin Oncol2023
37086362ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer.Support Care Cancer2023
36980749Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based Study.Cancers (Basel)2023
37305629A literature review to understand health literacy in men with prostate cancer on active surveillance.Transl Androl Urol2023
37128990Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.Future Oncol2023
37093833Mental wellbeing and quality of life in prostate cancer (MIND-P): Protocol for a multi-institutional prospective cohort study.PLoS One2023
37030077Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer.Eur J Cancer2023
36522475Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden.Br J Cancer2023
36812845Far-reaching impact of the Russian invasion of Ukraine on global cancer research.Eur J Cancer2023
36402875Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.Br J Cancer2023
36648569The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.Qual Life Res2023
36844872Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.J Oncol2023
36870852Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Oncol2023
36710133Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.Eur Urol Oncol2023
36940675Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England.Neuroendocrinology2023
35972811Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic.J Eur Acad Dermatol Venereol2023
36008540Risk of progression following a negative biopsy in prostate cancer active surveillance.Prostate Cancer Prostatic Dis2023
34260693Transition from esophagectomy to endoscopic therapy for early esophageal cancer.Dis Esophagus2022
35510135COVID-19 vaccination in patients with cancer, a rapid review.Ecancermedicalscience2022
35382557Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic.Future Oncol2022
35840733Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.Br J Cancer2022
35380164Antibodies as biomarkers for cancer risk: a systematic review.Clin Exp Immunol2022
35379637Diagnostic and prognostic factors in patients with prostate cancer: a systematic review.BMJ Open2022
35576848Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry.Eur J Cancer2022
35397545Invadopodia play a role in prostate cancer progression.BMC Cancer2022
35629173Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform.J Pers Med2022
35488333Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.BMC Urol2022
35783588Impact of the COVID-19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan.BJUI Compass2022
35417006COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.J Natl Cancer Inst2022
35559868Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England.J Cancer Policy2022
36551542Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age &lt; 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World StudyCancers (Basel)2022
36578462A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer.Eur Urol Open Sci2022
36569508Developing a consensus statement for psychosocial support in active surveillance for prostate cancer.BJUI Compass2022
36525457Undergoing radical treatment for prostate cancer and its impact on wellbeing: A qualitative study exploring men's experiences.PLoS One2022
35939302Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes.JAMA Netw Open2022
36176500Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based study.Lancet Reg Health Eur2022
36172860Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre.Future Oncol2022
36033807Editorial: The effects of COVID-19 on cancer research methods &amp; strategies.Front Public Health2022
  • 1 - 50 of 342

Recommended Authors

Katherine Lajkosz
Princess Margaret Hospital
Career Start Year 2017
Number of shared co-authors 3
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 9
Martin Goros
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Mara M Epstein
University of Massachusetts Chan Medical School
Career Start Year 2011
Number of shared co-authors 1
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 1
Jaeil Ahn
Georgetown University
Career Start Year 2008
Number of shared co-authors 4
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 2
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Marco Randazzo
Winterthur Cantonal Hospital
Career Start Year 2005
Number of shared co-authors 2
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 5
Channing J Paller
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Jeanine M Genkinger
Mailman School of Public Health, Columbia University
Career Start Year 2001
Number of shared co-authors 1
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 3
Reina Haque
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 0
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 3
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 8
Stephen J Freedland
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 14
Ming-Hui Chen
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 3
Henrik Gr??nberg
Karolinska Institute
Career Start Year 1993
Number of shared co-authors 14
Edward L Giovannucci
Harvard T.H. Chan School of Public Health
Career Start Year 1990
Number of shared co-authors 12
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 1
N??ria Malats
Spanish National Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 6
Neil E Fleshner
University of Toronto
Career Start Year 1989
Number of shared co-authors 12
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 21
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 5
Stephen K Van Den Eeden
Kaiser Permanente Northern California, University of California san francisco
Career Start Year 1985
Number of shared co-authors 5
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 9
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 7
Loren Lipworth
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 1964
Number of shared co-authors 3

Collaborators

Celia Moss
King's College London
Co-authored papers 42
Declan Cahill
Royal Marsden Hospital NHS Trust
Co-authored papers 17
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 12
Björn Zethelius
Co-authored papers 11
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 8
Alex Asiimwe
Bayer Pharma AG
Co-authored papers 8
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Co-authored papers 8
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 7
Philip Cornford
Liverpool University Hospitals
Co-authored papers 6
Lorelei A Mucci
Co-authored papers 6
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 6
Alberto Zambelli
IRCCS Humanitas Research Hospital
Co-authored papers 5
James N'Dow
University of Aberdeen
Co-authored papers 5
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 5
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Co-authored papers 5
Mark Frydenberg
Monash University
Co-authored papers 4
Sebastiaan Remmers
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 4
Conjeevaram S Pramesh
Homi Bhabha National Institute
Co-authored papers 4
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 3
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 3
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 3
Lorenzo Chiudinelli
Papa Giovanni XXIII Hospital
Co-authored papers 3
Emma J Smith
University of Guelph
Co-authored papers 3
Asieh Golozar
Northeastern University
Co-authored papers 3
Elizabeth Selvin
Co-authored papers 2
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Co-authored papers 2
Bertrand De Meulder
European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM
Co-authored papers 2
Rachel H Giles
University Medical Center Utrecht
Co-authored papers 2
Riccardo Campi
Careggi University Hospital
Co-authored papers 2
Tim Hulsen
Department of Hospital Services & Informatics
Co-authored papers 2
Release 1.2